20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine in 58 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) | Trials (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) | Recent Studies (post-2010) (n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine) |
---|---|---|---|---|---|
640 | 13 | 233 | 81 | 0 | 37 |
Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine (IC50) |
---|---|---|---|
Cytochrome P450 1A2 | Homo sapiens (human) | 0.461 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.1 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.1 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 2.935 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.272 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 33 (56.90) | 29.6817 |
2010's | 22 (37.93) | 24.3611 |
2020's | 3 (5.17) | 2.80 |
Authors | Studies |
---|---|
Doi, M; Ishimoto, T; Kameo, K; Kametani, S; Miyata, N; Sato, M; Sato-Watanabe, M; Seki, T; Taniguchi, K; Tomishima, Y; Ueki, T; Yasuda, Y | 1 |
Amada, H; Ishii, T; Kameo, K; Kobayashi-Matsunaga, Y; Miyata, N; Sato, M; Taniguchi, K | 1 |
Cambj-Sapunar, L; Harder, DR; Hudetz, AG; Kametani, S; Kehl, F; Maier, KG; Miyata, N; Okamoto, H; Roman, RJ; Schulte, ML; Zagorac, D | 1 |
Amaral, SL; Greene, AS; Maier, KG; Roman, RJ; Schippers, DN | 1 |
Cambj-Sapunar, L; Harder, DR; Roman, RJ; Yu, M | 1 |
Flasch, AK; Hoagland, KM; Roman, RJ | 1 |
Abraham, NG; Byun, K; Falck, JR; Jiang, M; Kemp, R; Laniado-Schwartzman, M; Mezentsev, A; Miano, JM; Nasjletti, A | 1 |
Chen, P; Edwards, PA; Falck, JR; Guo, M; Roman, RJ; Scicli, AG; Wygle, D | 1 |
Akhtar, S; Benter, IF; Canatan, H; Yousif, MH | 1 |
Edwards, PA; Falck, JR; Guo, M; Roman, RJ; Scicli, AG | 1 |
Laniado-Schwartzman, M; Miyata, N; Seki, T; Wang, MH | 1 |
Doggrell, SA | 1 |
Metea, MR; Newman, EA | 1 |
Bies, RR; Graham, SH; Kochanek, PM; Poloyac, SM; Zhang, Y | 1 |
Caron, N; Flamion, B; Imig, JD; Joly, E; Kramp, R; Michel, A; Seqqat, R | 1 |
Blanton, A; Hercule, H; Nsaif, R; Oyekan, A | 1 |
Flasch, AK; Lopez, B; Roman, RJ; Ryan, RP; Sarkis, A; Williams, JM | 1 |
Badzyńska, B; Kompanowska-Jezierska, E; Kuczeriszka, M | 1 |
Anjaiahh, S; Falck, JR; Roman, RJ; Sharma, M; Williams, JM | 1 |
Cheng, J; Deng, H; Ishizuka, T; Kemp, R; Nasjletti, A; Schwartzman, ML; Singh, H | 1 |
Bridges, AS; Hall, JE; Kornbluth, S; Paine, MF; Tidwell, RR; Wang, MZ; Wu, JQ; Zeldin, DC | 1 |
Falck, JR; Harder, DR; Koehler, RC; Li, C; Liu, X; Roman, RJ | 1 |
Avner, ED; Jia, G; Park, F; Roman, RJ; Sweeney, WE | 1 |
Graham, SH; Klamerus, MM; Miller, TM; Mu, Y; Poloyac, SM; Rohan, LC | 1 |
Ao, Y; Cheng, H; Li, Y; Lv, X; Peng, R; Wan, J; Yang, J | 1 |
Dunn, KM; Falck, J; Flasch, AK; Harder, DR; Renic, M; Roman, RJ | 1 |
Akbulut, T; Avner, ED; Birudaraju, S; Falck, JR; Jia, G; Mueller, B; Park, F; Roman, RJ; Sweeney, WE | 1 |
Cao, S; Harder, DR; Koehler, RC; Kwansa, H; Roman, RJ; Wang, LC | 1 |
Akhtar, S; Benter, IF; Dahly-Vernon, AJ; Dunn, KM; Roman, RJ; Yousif, MH | 1 |
Benter, IF; Roman, RJ; Yousif, MH | 1 |
Croft, KD; Mori, TA; Ong, SL; Temple, SE; Vickers, JJ; Whitworth, JA; Wu, JH; Zhang, Y | 1 |
Alexanian, A; Flasch, A; Miller, B; Roman, RJ; Rufanova, VA; Sorokin, A | 1 |
Azma, T; Hama-Tomioka, K; Hatakeyama, N; Hatano, Y; Kikuchi, H; Kinoshita, H; Matsuda, N; Nakahata, K | 1 |
Benter, IF; Yousif, MH | 1 |
Abraham, NG; Cheng, J; Falck, JR; Goli, M; Gotlinger, K; Inoue, K; Schwartzman, ML; Sodhi, K; Wu, CC | 1 |
Barden, A; Beilin, LJ; Croft, KD; Puddey, IB; Tsai, IJ | 1 |
Bao, Y; Han, Y; Huo, D; Li, W; Shen, X; Sun, C; Tan, J; Wang, X; Zeng, Q | 1 |
Cervenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kopkan, L; Kramer, HJ; Sporková, A; Varcabová, S | 1 |
Harris, NR; Leskova, W; Wang, Z; Yadav, AS | 1 |
Falck, JR; Florence, MA; Gebremedhin, D; Gerges, NZ; Harder, DR; Kumar, SN; Renic, M; Roman, RJ | 1 |
Carter, EL; Crafa, DA; Harder, DR; Kibler, KK; Koehler, RC; Kwansa, H; Martin, LJ; Roman, RJ; Yang, ZJ | 1 |
Li, J; Li, QX; Tian, T; Wang, MY; Xie, XF | 1 |
Fernandez, MM; Gonzalez, D; Nowicki, S; Roman, RJ; Williams, JM | 1 |
Lai, G; Liu, X; Wu, J; Zhao, Y | 1 |
Cseplo, P; Csiszar, A; Koller, A; Sonntag, WE; Sosnowska, D; Springo, Z; Tarantini, S; Toth, P; Tucsek, Z; Ungvari, Z | 1 |
Baker, RC; Chen, BB; Fan, F; Johnson, DA; Liu, H; Orozco, LD; Perkins, E; Roman, RJ | 1 |
Armstrong, JS; Bhalala, US; Koehler, RC; Kulikowicz, E; Lee, JH; Martin, LJ; Wang, B; Yang, ZJ; Zhu, J | 1 |
Alexander, H; Clark, RS; Kochanek, PM; Manole, MD; Poloyac, SM; Shaik, JS; Tudorascu, DL | 1 |
Che, D; Chen, J; Hammock, BD; Huang, F; Huang, H; Liu, Y; Qiu, K; Wang, J; Wang, MH; Yang, X | 1 |
Ćosić, A; Drenjančević, I; Mihalj, M; Mišir, M; Novak, S; Renić, M; Vesel, M | 1 |
Amaral, LM; Cunningham, MW; Faulkner, JL; LaMarca, B; Murphy, S; Plenty, NL; Wallace, K | 1 |
Amorosi, CJ; Dunham, MJ; Fowler, DM; Gallis, B; Kowalski, JP; McDonald, MG; Nath, A; Paco, L; Ray, S; Rettie, AE; Sitko, KA; Totah, RA | 1 |
Aslan, M; Basralı, F; Nasırcılar Ülker, S; Özcan, F; Özen, N; Şentürk, ÜK; Ülker, P | 1 |
Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J | 1 |
Babapoor-Farrokhran, S; Hu, K; Kannan, S; Koehler, RC; Kulikowicz, E; Robertson, CL; Shu, S; Spicer, D; Zhang, Z | 1 |
Cárdenas, S; Colombero, C; Costas, MA; Dakarapu, R; Falck, JR; Nowicki, S; Panelo, L | 1 |
Lian, G; Luo, L; Wang, H; Wang, J; Wang, T; Xie, L; Xu, C | 1 |
Cui, W; Du, Y; Feng, D; Ge, S; Guo, W; Liu, H; Luo, J; Qu, Y; Shi, Y; Wang, P; Wang, Q; Wu, X; Zheng, L | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine
Article | Year |
---|---|
Taking the 20-HETE out of the cardiovascular system: the potential of 20-HETE synthesis inhibitors.
Topics: Amidines; Angiogenesis Inhibitors; Animals; Cerebrovascular Circulation; Enzyme Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Myocardial Reperfusion Injury; Oligonucleotides, Antisense | 2005 |
57 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine
Article | Year |
---|---|
HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.
Topics: Amidines; Animals; Arachidonic Acid; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Mixed Function Oxygenases; Rats; Rats, Inbred SHR; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2001 |
Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor.
Topics: Amidines; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Hydroxyeicosatetraenoic Acids; Inhibitory Concentration 50; Kidney; Microsomes; Structure-Activity Relationship | 2001 |
20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
Topics: Amidines; Animals; Carbon Dioxide; Cerebrovascular Circulation; Enzyme Inhibitors; Erythrocytes; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Microscopy, Video; Partial Pressure; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Subarachnoid Hemorrhage; Time Factors | 2002 |
CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis.
Topics: Amidines; Animals; Antibodies; Arachidonic Acid; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Electric Stimulation; Endothelial Growth Factors; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mixed Function Oxygenases; Muscle, Skeletal; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
Topics: Amidines; Animals; Blood; Brain Ischemia; Calcium Signaling; Cerebrospinal Fluid; Cerebrovascular Circulation; Cisterna Magna; Eicosanoic Acids; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Injections; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Phospholipases A; Propanolamines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Subarachnoid Hemorrhage; Vascular Resistance; Vasoconstriction; Vasospasm, Intracranial | 2003 |
Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats.
Topics: Amidines; Animals; Arachidonic Acid; Blood Pressure; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Rats; Rats, Sprague-Dawley; Sodium Chloride; Triazoles | 2003 |
Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels.
Topics: 3T3 Cells; Adenoviridae; Amidines; Animals; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Enzyme Inhibitors; Genetic Vectors; Humans; Hydroxyeicosatetraenoic Acids; Lauric Acids; Male; Mice; Microfilament Proteins; Muscle Proteins; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Organ Specificity; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Renal Artery; Transduction, Genetic; Vascular Endothelial Growth Factor A | 2004 |
Inhibitors of cytochrome P450 4A suppress angiogenic responses.
Topics: Amides; Amidines; Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cornea; Cytochrome P-450 CYP4A; DNA, Complementary; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Hydroxyeicosatetraenoic Acids; Male; Mitogens; Neovascularization, Pathologic; Polymerase Chain Reaction; Polymers; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery.
Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation | 2005 |
Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
Topics: Amidines; Antineoplastic Agents; Arachidonic Acid; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP4A; DNA Fragmentation; Enzyme Inhibitors; ErbB Receptors; Flow Cytometry; Glioma; Humans; Hydroxyeicosatetraenoic Acids; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinase 1; Mitosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Thymidine | 2005 |
Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Arachidonic Acid; Cell Membrane; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Kinetics; Oxidation-Reduction; Rats | 2005 |
Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling.
Topics: 8,11,14-Eicosatrienoic Acid; Adenosine Triphosphate; Amidines; Animals; Arterioles; Calcium Signaling; Caproates; Cyclic N-Oxides; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Eye Proteins; Hydrazines; Hydroxyeicosatetraenoic Acids; Imidazoles; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Male; Miconazole; Neuroglia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Photolysis; Proadifen; Purinergic Antagonists; Rats; Rats, Long-Evans; Retinal Vessels; Signal Transduction; Vasoconstriction; Vasodilation; Vasomotor System | 2006 |
Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
Topics: Amidines; Animals; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Vasoconstriction | 2006 |
Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE.
Topics: Adaptation, Physiological; Amidines; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Dinoprostone; Hydroxyeicosatetraenoic Acids; Imidazoles; Indomethacin; Losartan; Male; Microcirculation; Nephrectomy; Norepinephrine; Pyridines; Rats; Rats, Wistar; Renal Circulation; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Nitric oxide/cytochrome P450 interactions in cyclosporin A-induced effects in the rat.
Topics: Amidines; Animals; Arginine; Blood Pressure; Bradykinin; Cyclosporine; Cytochrome P-450 Enzyme System; Endothelin-1; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Nitric Oxide; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Triazoles | 2006 |
Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis.
Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Enzyme Inhibitors; Hydrostatic Pressure; Hydroxyeicosatetraenoic Acids; Kidney Cortex; Male; Natriuresis; Rats; Triazoles | 2007 |
Cytochrome P-450 monooxygenases in control of renal haemodynamics and arterial pressure in anaesthetized rats.
Topics: Amidines; Animals; Arachidonic Acid; Blood Pressure; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Hemodynamics; Hydroxyeicosatetraenoic Acids; Kidney; Kidney Cortex; Kidney Medulla; Laser-Doppler Flowmetry; Male; Nitric Oxide; Rats; Rats, Wistar; Renal Circulation; Triazoles; Vasoconstrictor Agents; Vasodilation | 2006 |
Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
Topics: Amides; Amidines; Animals; Arachidonic Acid; Cytochrome P-450 Enzyme System; Hydroxyeicosatetraenoic Acids; Kidney Glomerulus; Male; Permeability; Proteins; Rats; Rats, Sprague-Dawley | 2007 |
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
Topics: Acetylcholine; Amidines; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Dihydrotestosterone; Drug Synergism; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Vasodilation; Vasodilator Agents | 2007 |
Human enteric microsomal CYP4F enzymes O-demethylate the antiparasitic prodrug pafuramidine.
Topics: Amidines; Antibodies; Antiparasitic Agents; Arachidonic Acid; Benzamidines; Benzoflavones; Butyrophenones; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hydroxyeicosatetraenoic Acids; Intestinal Mucosa; Intestines; Kinetics; Methylation; Microsomes; Oxygenases; Piperidines; Prodrugs; Recombinant Proteins; Stereoisomerism | 2007 |
Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Cerebral Cortex; Cerebrovascular Circulation; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hyperemia; Indazoles; Male; Mechanotransduction, Cellular; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons, Afferent; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Physical Stimulation; Rats; Rats, Wistar; Time Factors; Vasodilation; Vibrissae | 2008 |
20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.
Topics: Amidines; Animals; Cell Culture Techniques; Cell Proliferation; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Epithelial Cells; Hydroxyeicosatetraenoic Acids; Mice; Mice, Inbred BALB C; Polycystic Kidney Diseases | 2008 |
Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
Topics: Amidines; Animals; Brain; Chemistry, Pharmaceutical; Cytochrome P-450 Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley | 2008 |
Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion.
Topics: Amides; Amidines; Animals; Apoptosis; Caspase 3; Cytochrome P-450 CYP4A; Enzyme Activation; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Sulfones | 2008 |
Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
Topics: Amidines; Animals; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Infarction, Middle Cerebral Artery; Isoenzymes; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Severity of Illness Index; Stroke; Time Factors; Up-Regulation | 2008 |
Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Cyclic AMP; Cytochrome P-450 CYP4A; Disease Models, Animal; Enzyme Activation; Epoxy Compounds; Extracellular Signal-Regulated MAP Kinases; Hydroxyeicosatetraenoic Acids; Kidney; Male; Microsomes; Organ Size; Polycystic Kidney, Autosomal Recessive; Protein Isoforms; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2009 |
Endothelin rather than 20-HETE contributes to loss of pial arteriolar dilation during focal cerebral ischemia with and without polymeric hemoglobin transfusion.
Topics: Amidines; Animals; Arterioles; Blood Substitutes; Blood Transfusion; Brain Ischemia; Endothelin A Receptor Antagonists; Endothelins; Hemoglobins; Hydroxyeicosatetraenoic Acids; Male; Models, Animal; Oligopeptides; Pia Mater; Polymers; Rats; Rats, Wistar; Regional Blood Flow; Vasodilation | 2009 |
Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes.
Topics: Amidines; Angiotensin II; Animals; Blood Glucose; Body Weight; Carbachol; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Endothelin-1; Enzyme Inhibitors; Histamine; Hydroxyeicosatetraenoic Acids; Kidney; Male; Mesenteric Arteries; Microsomes; Nitroprusside; Norepinephrine; Perfusion; Rats; Rats, Wistar; Renal Artery; Triazoles; Vasoconstriction; Vasodilation | 2009 |
Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury.
Topics: 8,11,14-Eicosatrienoic Acid; Amidines; Animals; Arachidonic Acid; Blood Glucose; Body Weight; Coronary Circulation; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Epoxide Hydrolases; Glyburide; Heart; Hydroxyeicosatetraenoic Acids; Male; Microsomes; Myocardium; Rats; Rats, Wistar; Reperfusion Injury; Urea; Vascular Resistance; Ventricular Dysfunction, Left | 2009 |
The role of 20-hydroxyeicosatetraenoic acid in adrenocorticotrophic hormone and dexamethasone-induced hypertension.
Topics: Adrenocorticotropic Hormone; Amidines; Animals; Body Weight; Dexamethasone; F2-Isoprostanes; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Nitrogen Species; Systole | 2009 |
Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.
Topics: Amidines; Animals; Arachidonic Acid; Carcinoma, Renal Cell; Cell Growth Processes; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Down-Regulation; Humans; Hydroxyeicosatetraenoic Acids; Kidney Neoplasms; Mice; Mice, Nude; RNA, Messenger; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2009 |
The role of 20-hydroxyeicosatetraenoic acid in cerebral arteriolar constriction and the inhibitory effect of propofol.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Amidines; Anesthetics, Intravenous; Animals; Arterioles; Cell-Free System; Cerebral Arteries; Electric Stimulation; Enzyme Inhibitors; Free Radical Scavengers; Glycoproteins; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Male; Microscopy, Video; NADPH Oxidases; Onium Compounds; Propofol; Rats; Rats, Wistar; Sodium Channel Blockers; Superoxides; Tetrodotoxin; Time Factors; Vasoconstriction | 2009 |
Role of 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of vascular function in a model of hypertension and endothelial dysfunction.
Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Carbachol; Cardiovascular Physiological Phenomena; Carotid Arteries; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Urea; Vascular Diseases; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2010 |
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent.
Topics: Amidines; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Cells, Cultured; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Lentivirus; Lisinopril; Losartan; Mass Spectrometry; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Time Factors | 2010 |
20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.
Topics: Adult; Aged; Amidines; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Platelets; Calcium Channels; Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Endothelin-1; Humans; Hydroxyeicosatetraenoic Acids; Imidazoles; Ionophores; Irbesartan; Male; Middle Aged; Neutrophils; Oligopeptides; Peptides, Cyclic; Piperidines; Pyridines; Tetrazoles; Young Adult | 2011 |
20-Hydroxyeicosatetraenoic acid induces apoptosis in neonatal rat cardiomyocytes through mitochondrial-dependent pathways.
Topics: Amidines; Animals; Animals, Newborn; Apoptosis; Arachidonic Acid; bcl-2-Associated X Protein; Benzimidazoles; Carbocyanines; Caspase 3; Cell Survival; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Fluorescent Dyes; Genes, bcl-2; Hydroxyeicosatetraenoic Acids; Hydroxylation; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction; Staining and Labeling | 2011 |
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.
Topics: Amidines; Animals; Arachidonic Acids; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Hydroxyeicosatetraenoic Acids; Hypertension, Renovascular; Kidney; Male; Rats; Regional Blood Flow; Sodium | 2011 |
Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.
Topics: Amidines; Animals; Blood Flow Velocity; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Erythrocytes; Hydroxyeicosatetraenoic Acids; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Regional Blood Flow; Retinal Vessels | 2011 |
Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures.
Topics: Amidines; Animals; Animals, Newborn; Caspase 3; Cell Death; Cell Hypoxia; Cytoprotection; Glucose; Hippocampus; Hydroxyeicosatetraenoic Acids; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Superoxides; Time Factors; Tissue Culture Techniques | 2012 |
Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor.
Topics: Amidines; Animals; Animals, Newborn; Brain Ischemia; Hydroxyeicosatetraenoic Acids; Infusions, Intraventricular; Male; Swine | 2012 |
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on adriamycin-induced toxicity of human renal tubular epithelial cell (HK-2).
Topics: Amidines; Antibiotics, Antineoplastic; Cell Line; Cell Survival; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Doxorubicin; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation, Enzymologic; Humans; Hydroxyeicosatetraenoic Acids; Kidney Tubules; Osmolar Concentration; Protective Agents; RNA, Messenger | 2012 |
Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine.
Topics: Amidines; Animals; Cytochrome P-450 CYP4A; Dopamine; Glomerular Filtration Rate; Hydroxyeicosatetraenoic Acids; Kidney Cortex; Liver; Male; Natriuretic Agents; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Triazoles | 2012 |
20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.
Topics: Amidines; Animals; Blood Glucose; Cell Line; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytochrome P-450 Enzyme System; Glucose Transporter Type 1; Glycogen Phosphorylase; Hydroxyeicosatetraenoic Acids; Hyperglycemia; Hypertension; Insulin Receptor Substrate Proteins; Isoquinolines; Liver; Male; Mice; Mice, Transgenic; Phosphorylase Kinase; Phosphorylation; Signal Transduction; Sulfonamides | 2012 |
Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.
Topics: Amidines; Animals; Blood Pressure; Cells, Cultured; Cerebrovascular Disorders; Cytochrome P-450 Enzyme System; Cytokines; Hydroxyeicosatetraenoic Acids; Male; Middle Cerebral Artery; NF-kappa B; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Vasomotor System | 2013 |
20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
Topics: Amidines; Angioplasty, Balloon, Coronary; Animals; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Movement; Cell Proliferation; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Disease Models, Animal; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hyperplasia; Male; Muscle, Smooth, Vascular; Neointima; Rats; Rats, Sprague-Dawley; Triazoles; Tunica Intima | 2013 |
Additive Neuroprotection of a 20-HETE Inhibitor with Delayed Therapeutic Hypothermia after Hypoxia-Ischemia in Neonatal Piglets.
Topics: Amidines; Animals; Animals, Newborn; Cytochrome P-450 CYP4A; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Swine | 2015 |
20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats.
Topics: Amidines; Animals; Asphyxia Neonatorum; Body Water; Brain Chemistry; Brain Edema; Cerebral Cortex; Cerebrovascular Circulation; Cytochrome P-450 Enzyme System; Eicosanoids; Heart Arrest; Hydroxyeicosatetraenoic Acids; Male; Neurodegenerative Diseases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
Topics: Amidines; Angiogenesis Inducing Agents; Animals; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Drugs, Chinese Herbal; Endothelial Progenitor Cells; Hydroxyeicosatetraenoic Acids; Male; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |
Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
Topics: Amidines; Animals; Aryl Hydrocarbon Hydroxylases; Brain; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 4; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epoxide Hydrolases; Female; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Time Factors | 2017 |
Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia.
Topics: Amidines; Animals; Blood Pressure; Cytochrome P-450 Enzyme System; Disease Models, Animal; Female; Hydroxyeicosatetraenoic Acids; Pre-Eclampsia; Pregnancy; Rats | 2018 |
Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in
Topics: Amidines; Breast Neoplasms; Cytochrome P450 Family 4; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxylation; Interleukin-1 Receptor-Associated Kinases; Lauric Acids; Mass Spectrometry; Microsomes, Liver; Molecular Docking Simulation; Oxidation-Reduction; Recombinant Proteins; Saccharomyces cerevisiae | 2017 |
Effect of 20-HETE inhibition on L-NAME-induced hypertension in rats.
Topics: Amidines; Animals; Blood Pressure; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Tissue Culture Techniques; Vascular Resistance; Vasoconstriction; Vasodilation | 2018 |
Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Topics: Amidines; Anilides; Animals; Cell Line; Cytochrome P-450 CYP4A; Diabetic Nephropathies; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Glucose; Hydroxyeicosatetraenoic Acids; Indoles; Kidney Tubules; Male; Mice; PPAR alpha; PPAR gamma; PPAR-beta; Rats; Sulfones; Thiophenes | 2019 |
Administration of a 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor Improves Outcome in a Rat Model of Pediatric Traumatic Brain Injury.
Topics: Amidines; Animals; Brain; Brain Injuries, Traumatic; Cytokines; Disease Models, Animal; Hydroxyeicosatetraenoic Acids; Inflammation; Male; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells.
Topics: Amidines; Androgens; Cell Movement; Epithelial-Mesenchymal Transition; Gene Knockdown Techniques; Humans; Hydroxyeicosatetraenoic Acids; Intracellular Signaling Peptides and Proteins; LIM Domain Proteins; Male; Matrix Metalloproteinase 2; PC-3 Cells; Prostatic Neoplasms; Receptors, G-Protein-Coupled; RNA, Small Interfering; Signal Transduction | 2020 |
Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells.
Topics: Amidines; Animals; Cell Proliferation; Chromatography, Liquid; Hydroxyeicosatetraenoic Acids; Hypertension, Pulmonary; Hypoxia; Male; Myocytes, Smooth Muscle; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2020 |
20-HETE synthesis inhibition attenuates traumatic brain injury-induced mitochondrial dysfunction and neuronal apoptosis via the SIRT1/PGC-1α pathway: A translational study.
Topics: Amidines; Animals; Apoptosis; Brain Injuries, Traumatic; Dynamins; Female; Humans; Hydroxyeicosatetraenoic Acids; Logistic Models; Male; Mice; Mice, Inbred C57BL; Middle Aged; Mitochondria; Mitochondrial Dynamics; Neurons; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Reactive Oxygen Species; Signal Transduction; Sirtuin 1 | 2021 |